Produksi Biosimilar Okriplasmin Indonesia

• 

  Cutting-Edge Technology and Manufacturing Processes for Ocriplasmin Biosimilar

  The team at Yaohai has put a lot of time and effort into developing the best technology and techniques for the manufacturing of Ocriplasmin Biosimilar. Taking account of all this hard work means they create safe final products for patients. Yaohai wants the treatment to work well and be cheap, so it can be available to more people. With the aid of these modernised technologies, they can guarantee giving patients top-notch care.

• 

  Ensuring Safety and Efficacy through Rigorous Quality Control Measures

  When it has to do with making new treatments, Yaohai is significant about safety and effectiveness. For Manufaktur Semaglutida GMP, they cross-verify everything step by step with meticulous care. Execution of each procedure in manufacturing the product are tested and examined carefully to assure high quality and reliability. The guarantee of its safety and effectiveness that Yaohai provides has also made it an outstanding example in the healthcare industry. They think that the treatments should always be trusted completely by the patients.

• 

  Advancing Patient Care with Cost-Effective Solutions.

  Yaohai API Semaglutida GMP realises that cost can be tough, particularly for many patients who require such treatments. That is why Ocriplasmin Biosimilar is not only effective for the eye but also cheap. Yaohai wishes to ensure patients receive the care they need at an affordable rate. For Yaohai, this promise to maintain the affordability and availability of treatments is crucial. EVERYONE deserves to be given the opportunity for better health and better life.

Why choose Yaohai Ocriplasmin Biosimilar Production?

• Kustomisasi, Efisiensi & Efektivitas Biaya

  Yaohai Bio-Pharma is experienced in the development of microbial-derived biologics We offer tailored RD solutions and manufacturing while keeping risks to a minimum We have used a variety of modalities including recombinant subunits vaccines (including peptides) growth factors hormones and Cytokines We've specialized in several microorganisms like yeast intracellular and extracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion body (yields as high as 10g/L) We have also created a Ocriplasmin Biosimilar Production fermentation system to develop bacteria-based vaccines We are experts in optimizing processes increasing yields as well as reducing production costs Utilizing a strong technology team we ensure timely and quality project delivery to bring your exclusive products to market faster

• Rantai Pasokan & Kemampuan Manufaktur yang Kuat

  Yaohai Bio-Pharma, a top 10 Ocriplasmin Biosimilar Production of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

• Keahlian Profesional & Pengalaman Luas

  Yaohai Bio-Pharma, a leader in CDMOs for microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are Ocriplasmin Biosimilar Production for human, veterinary as well as pet health management. We have the most cutting-edge RD platforms as well as manufacturing technology that cover the entire manufacturing process, from microbial strain development, cell banking, process and method development to clinical and commercial manufacture which ensures successful production of novel solutions. We have gained an extensive amount of experience in bio processing of microbial cells. More than 200 projects have been successfully completed, and we support our clients in get through regulations, such as those of US FDA as well as EU EMA. We also aid them with Australia TGA and China NMPA. Our experience and professional knowledge as well as our extensive knowledge allow us to quickly respond to market demands and provide customized CDMO services.

• Sistem Mutu & Kepatuhan Terhadap Peraturan Global

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Ocriplasmin Biosimilar Production, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

Kategori produk terkait

• Produksi Biosimilar Glukarpidase
• Pengembangan dan Pembuatan Biosimilar Mikroba
• Produksi Biosimilar PTH 1-34

Tidak menemukan apa yang Anda cari?
Hubungi konsultan kami untuk lebih banyak produk yang tersedia.